Literature DB >> 18937596

The effects of triclosan on uropathogen susceptibility to clinically relevant antibiotics.

Geoffrey R Wignall1, Lee W Goneau, Ben H Chew, John D Denstedt, Peter A Cadieux.   

Abstract

INTRODUCTION: Triclosan is a broad-spectrum antimicrobial agent currently used in numerous products including surgical scrubs and ureteral stents. Unfortunately, studies have shown triclosan resistance among several bacterial species. Our objective was to characterize resistance patterns of common uropathogens to triclosan and determine whether triclosan exposure would alter their susceptibility to common antibiotics. We hypothesized that triclosan exposure induces a metabolic stress rendering some bacterial strains more susceptible to other antibiotics.
METHODS: Using largely clinical isolates comprising seven uropathogenic species, we conducted 24 hour growth experiments to determine triclosan minimal inhibitory concentrations (MIC) for each strain. Based upon these MICs, triclosan was added to agar plates at escalating sublethal concentrations and antibiotic disk diffusion assays were conducted using a range of clinically-relevant antibiotics.
RESULTS: Varying susceptibility patterns were observed across all antibiotics studied. Several antibiotics demonstrated increased efficacy in conjunction with triclosan. The combined effect of triclosan with amoxicillin and gentamicin was superior when considering significant increases in susceptibility, with 6 (86%) and 5 (71%) of the 7 bacterial strains displaying enhanced sensitivity, respectively. The antimicrobial effects of nitrofurantoin and the fluoroquinolones were significantly enhanced for 4 (57%), 4 and 3 (42%) of the 7 pathogens, respectively. The two fluoroquinolones were the only antibiotics where susceptibility was negatively impacted (in one strain each) in combination with triclosan.
CONCLUSIONS: The synergistic effects of triclosan and several antibiotics are consistent with a triclosan-dependent metabolic strain and/or membrane disruptive effect, and offers important insight into the combined use of antimicrobial compounds in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18937596     DOI: 10.1089/end.2008.9705

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  5 in total

1.  Validation of a High-Throughput Screening Assay for Identification of Adjunctive and Directly Acting Antimicrobials Targeting Carbapenem-Resistant Enterobacteriaceae.

Authors:  Kenneth P Smith; James E Kirby
Journal:  Assay Drug Dev Technol       Date:  2016-04-05       Impact factor: 1.738

Review 2.  Ureteral stent technology: Drug-eluting stents and stent coatings.

Authors:  Luo Yang; Samantha Whiteside; Peter A Cadieux; John D Denstedt
Journal:  Asian J Urol       Date:  2015-09-21

Review 3.  Ureteral Stents and Foley Catheters-Associated Urinary Tract Infections: The Role of Coatings and Materials in Infection Prevention.

Authors:  Joey Lo; Dirk Lange; Ben H Chew
Journal:  Antibiotics (Basel)       Date:  2014-03-10

Review 4.  UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies.

Authors:  Maria E Terlizzi; Giorgio Gribaudo; Massimo E Maffei
Journal:  Front Microbiol       Date:  2017-08-15       Impact factor: 5.640

5.  Engineering solutions to ureteral stents: material, coating and design.

Authors:  Ali Mosayyebi; Aravinthan Vijayakumar; Qi Y Yue; Ewa Bres-Niewada; Costantino Manes; Dario Carugo; Bhaskar K Somani
Journal:  Cent European J Urol       Date:  2017-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.